Assessment of death risk of breast cancer patients with joint frailty models

References

1. ↵
   1. Bray F,
   2. Ferlay J,
   3. Soerjomataram I,
   4. Siegel RL,
   5. Torre LA,
   6. Jemal A

   (2018) Global cancer statistics. 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.

   OpenUrlCrossRefPubMed
2. ↵
   1. Ferlay J,
   2. Soerjomataram I,
   3. Dikshit R,
   4. Eser S,
   5. Mathers C,
   6. Rebelo M,
   7. et al.

   (2012) Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359–E386.

   OpenUrl
3. ↵
   1. Lafourcade A,
   2. His M,
   3. Baglietto L,
   4. Boutron-Ruault MC,
   5. Dossus L,
   6. et al.

   (2018) Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences:the French E3N cohort. BMC Cancer 18:1–9.

   OpenUrlCrossRefPubMed
4. ↵
   1. Neri A,
   2. Marrelli D,
   3. Rossi S

   (2007) Breast cancer local Recurrence:risk factors and prognostic relevance of early time to recurrence. World J Surg 31:36–45.

   OpenUrlCrossRefPubMed
5. ↵
   1. Haydaroglu A

   (2007) Meme Kanserinde İzlem. J Breast Health 3:95–99.

   OpenUrl
6. ↵
   1. Saphner T,
   2. Tormey DC,
   3. Gray R

   (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738–2746.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Gurtekin B

   (2011) Using propensity score method in analysing the variation age and ER, PR, CERB-B2 on the tissue in breast cancer. PhD, University of Istanbul, Istanbul, Turkey.
8. ↵
   1. Mitra N,
   2. Schnabel FR,
   3. Neugut AI,
   4. Heitjan DF

   (2001) Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis a propensity score analysis. Cancer 91:1709–1715.

   OpenUrlPubMed
9. ↵
   1. Oksuz DC

   (2015) Prognostic and predictive factors in breast cancer. Klinikleri J Radiat Oncol-Special Topics 1:7–12.

   OpenUrl
10. ↵
    1. Akbari ME,
    2. Akbari A,
    3. Nafissi N,
    4. Shormeij Z,
    5. Sayad S,
    6. et al.

    (2016) Prognostic factors of recurrence (early and late) and death in breast cancer patients in Iranian women. Iran J Cancer Prev 9:1–10.

    OpenUrl
11. ↵
    1. Rondeau V,
    2. Mathoulin-Pelissier S,
    3. Jacqmin-Gadda H,
    4. Brouste V,
    5. Soubeyran P

    (2007) Joint frailty models for recurring events and death using maximum penalized likelihood estimation:application on cancer events. Biostatistics 8:708–721.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Liu L,
    2. Wolfe RA,
    3. Huang X

    (2004) Shared frailty models for recurrent events and a terminal event. Biometrics 30:747–756.

    OpenUrl
13. ↵
    1. Belot A,
    2. Rondeau V,
    3. Remontet L,
    4. Giorgi R

    (2014) CENSUR working survival group. A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death. Stat Med 33:3147–3166.

    OpenUrl
14. ↵
    1. Mauguen A,
    2. Rachet B,
    3. Mathoulin-Pélissier S,
    4. MacGrogan G,
    5. Laurenta A,
    6. et al.

    (2013) Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models. Stat Med 32:5366–5380.

    OpenUrlCrossRefPubMed
15. ↵
    1. Steyerberg EW,
    2. Vickers AJ,
    3. Cook NR,
    4. Gerds T,
    5. Gonen M,
    6. et al.

    (2010) Assessing the performance of prediction models:a framework for traditional and novel measures. Epidemiology 21:128–138.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Kanyılmaz G,
    2. Yavuz BB,
    3. Aktan M,
    4. Karaağaç M,
    5. Uyar M,
    6. Fındık S

    (2019) Prognostic importance of Ki-67 in breast cancer and its relationship with other prognostic factors. Eur J Breast Health 15:256–261.

    OpenUrl
17. ↵
    1. Brandt J,
    2. Garne JP,
    3. Tengrup I,
    4. Manjer J

    (2015) Age at diagnosis in relation to survival following breast cancer:a cohort study. World Journal of Surgical Oncology 13:1–11.

    OpenUrlCrossRefPubMed
18. ↵
    1. Rondeau V,
    2. Mazroui Y,
    3. Gonzalez JR

    (2012) frailtypack:An R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation. J Stat Softw 47:1–28.

    OpenUrlCrossRef
19. ↵
    1. O'Shaughnessy J

    (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10:20–29.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Elkhuizen PHM,
    2. van de Vijver MJ,
    3. Hermans J,
    4. Zonderland HM,
    5. van de Velde CJH,
    6. et al.

    (1998) Local recurrence after breast-conserving therapy for invasive breast cancer:high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phy 40:859–867.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Osmani F,
    2. Hajizadeh E,
    3. Rasekhi AA

    (2018) Joint frailty modelling for multiple recurrent events and its application in patients with breast cancer. J Obstet Gynecol Cancer Res 3:53–58.

    OpenUrl
22. ↵
    1. Osmani F,
    2. Hajizadeh E,
    3. Rasekhi A,
    4. Akbari ME

    (2018) Analyzing relationships between local and metastasis relapses with survival of patients with breast cancer:A study using the joint frailty model. Int J Cancer Manag 11:1–7.

    OpenUrl
23. ↵
    1. Gohari MR,
    2. Mahmoudi M,
    3. Mohammed K,
    4. Pasha E,
    5. Khodabakhshi R

    (2006) Recurrence in breast cancer, analysis with the frailty model. Saudi Med J 27:1187–1193.

    OpenUrlPubMed